Get the Stockscreener App
31.01
4.41%
1.31
After Hours:
31.01
Omnicell Inc stock is traded at $31.01, with a volume of 1.05M.
It is up +4.41% in the last 24 hours and up +5.48% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$29.70
Open:
$33.75
24h Volume:
1.05M
Relative Volume:
1.72
Market Cap:
$1.45B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-67.41
EPS:
-0.46
Net Cash Flow:
$151.63M
1W Performance:
+10.24%
1M Performance:
+5.48%
6M Performance:
-31.07%
1Y Performance:
+6.16%
1-Day Range:
$28.90
$33.99
1-Week Range:
$27.77
$33.99
52-Week Range:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
31.01 | 1.39B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
284.20 | 46.88B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
56.59 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.00 | 8.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
58.75 | 11.03B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.17B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
What markets is SEAL.PRB expanding into Is Omnicell Inc. stock a good long term investment optionFree Stock Review Backed By Experts - jammulinksnews.com
Omnicell Raises Guidance After Outpacing Analyst Expectations - Finimize
Omnicell Q2 Earnings: Market Ignoring The Segments (NASDAQ:OMCL) - Seeking Alpha
Earnings call transcript: Omnicell Q2 2025 beats expectations with strong earnings By Investing.com - Investing.com South Africa
Earnings call transcript: Omnicell Q2 2025 beats expectations with strong earnings - Investing.com
Omnicell: Q2 Earnings Snapshot - The Washington Post
Omnicell Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Omnicell Shares Climb Over 2% After Second Quarter Results Surpass Expectations - MSN
How strong is Omnicell Inc. company’s balance sheetStock Market Picks With High Returns - jammulinksnews.com
Omnicell Q2 2025 slides: Revenue up 5%, shares jump on recurring revenue growth By Investing.com - Investing.com South Africa
Omnicell's Strategic Momentum and Earnings Outperformance: A Case for Upside in Automated Healthcare Solutions - AInvest
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Omnicell shares rise over 2% as second quarter results exceed expectations - Investing.com Nigeria
Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations - FinancialContent
Omnicell Announces Strong Q2 2025 Financial Results - TradingView
Omnicell Announces Second Quarter 2025 Results - Yahoo Finance
Is it the right time to buy Omnicell Inc. stockRetirement Planning Entry Points For Every Investor - jammulinksnews.com
Omnicell Earnings Announcement: What Investors Need to KnowNews and Statistics - IndexBox
Intrinsic Value of Omnicell Inc. Stock: Is It Undervalued or OvervaluedTriple Digit Growth Focused Trade Plan Reviewed - metal.it
Earnings To Watch: Omnicell (OMCL) Reports Q2 Results Tomorrow - Yahoo Finance
Published on: 2025-07-29 19:55:26 - metal.it
Why Omnicell Inc. stock attracts strong analyst attentionFast Exit and Entry Strategy Guide Offered - metal.it
Sector Rotation Brings Omnicell Inc. Into FocusStock Selection With High Accuracy Based on Models - beatles.ru
What makes Omnicell Inc. stock price move sharplyTarget Return Focused Trade Insights Shared - metal.it
What are Omnicell Inc. company’s key revenue driversRapid capital growth - jammulinksnews.com
What are the latest earnings results for Omnicell Inc.Capitalize on emerging market opportunities - jammulinksnews.com
What is the risk reward ratio of investing in Omnicell Inc. stockBreakthrough profit margins - jammulinksnews.com
What is Omnicell Inc. company’s growth strategyHigh-octane investment gains - jammulinksnews.com
Moving Average Trends for Omnicell Inc. Stock: What They IndicateFree Real-Time Stock Data - metal.it
Does Omnicell Inc. stock perform well during market downturnsBuild a balanced portfolio for long-term success - jammulinksnews.com
Analysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out for - MSN
How Omnicell Inc. stock reacts to Fed policy changesExplosive trading growth - jammulinksnews.com
Why Omnicell Inc. stock is on top investor watchlistsUnprecedented profits - jammulinksnews.com
Should I buy Omnicell Inc. stock before earningsMarket-beating returns - jammulinksnews.com
Omnicell Inc. Stock Analysis and ForecastTriple-digit growth rates - PrintWeekIndia
Pharmacy Automation Market Booming with Smart Dispensing - openPR.com
Omnicell's Path to Resilience: Navigating Short-Term Headwinds to Unlock Long-Term Value - AInvest
3 Healthcare Stocks We Approach with Caution - FinancialContent
What drives Omnicell Inc. stock priceRobust investment performance - jammulinksnews.com
Is Omnicell Inc. a good long term investmentOutstanding trading profits - jammulinksnews.com
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
3.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):